The risk of osteonecrosis of the jaws in taiwanese osteoporotic patients treated with oral alendronate or raloxifene

Journal of Clinical Endocrinology and Metabolism

Volumn 99, Issue 8, 2014, Pages 2729-2735

  Chiu, Wei Yih ^a,b   Chien, Jung Yien ^a,b   Yang, Wei Shiung ^a,b   Juang, Jyh Ming Jimmy ^a   Lee, Jang Jaer ^a   Tsai, Keh Sung ^a  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

ADMINISTRATION, ORAL; AGED; AGED, 80 AND OVER; ALENDRONATE; BISPHOSPHONATE-ASSOCIATED OSTEONECROSIS OF THE JAW; BONE DENSITY CONSERVATION AGENTS; FEMALE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; RALOXIFENE; RETROSPECTIVE STUDIES; RISK FACTORS; TAIWAN;

EID: 84905842171     PISSN: 0021972X     EISSN: 19457197     Source Type: Journal    
DOI: 10.1210/jc.2013-4119     Document Type: Article

References (16)

1. Khosla S, Burr D, Cauley J, et al. American Society for Bone and Mineral Research. Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research. J Bone Miner Res. 2007;22:1479-1491.
2. Ruggiero SL, Dodson TB, Assael LA, Landesberg R, MarxRE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws-2009 update. J Oral Maxillofac Surg. 2009;67:2-12.
3. Chiu WY, Lee JJ, Tsai KS. Atypical femoral fractures shortly after osteonecrosis of the jaw in a postmenopausal woman taking alendronate for osteoporosis. J Clin Endocrinol Metab. 2013;98:E723-E726.
4. Ott SM. What is the optimal duration of bisphosphonate therapy? Cleve Clin J Med. 2011;78:619-630.
5. Sedghizadeh PP, Stanley K, Caligiuri M, Hofkes S, Lowry B, Shuler CF. Oral bisphosphonate use and the prevalence of osteonecrosis of the jaw: an institutional inquiry. JAmDent Assoc. 2009;140:61-66.
6. Lo JC, O'Ryan FS, Gordon NP, et al. Predicting Risk of Osteonecrosis of the Jaw with Oral Bisphosphonate Exposure (PROBE) Investigators. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg. 2010;68: 243-253.
7. Lo JC, O'Ryan F, Yang J, et al. Oral health considerations in older women receiving oral bisphosphonate therapy. J Am Geriatr Soc. 2011;59:916-922.
8. Mavrokokki T, Cheng A, Stein B, Goss A. Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg. 2007;65:415-423.
9. Hansen PJ, Knitschke M, Draenert FG, Irle S, Neff A. Incidence of bisphosphonate-related osteonecrosis of the jaws (BRONJ) in patients taking bisphosphonates for osteoporosis treatment-a grossly underestimated risk? Clin Oral Investig. 2013;17(8):1829-1837.
10. Yamazaki T, Yamori M, Yamamoto K, et al. Risk of osteomyelitis of the jaw induced by oral bisphosphonates in patients taking medications for osteoporosis: a hospital-based cohort study in Japan. Bone. 2012;51:882-887.
11. Hong JW, Nam W, Cha IH, et al. Oral bisphosphonate-related osteonecrosis of the jaw: the first report in Asia. Osteoporos Int. 2010; 21:847-853.
12. Tennis P, Rothman KJ, Bohn RL, et al. Incidence of osteonecrosis of the jaw among users of bisphosphonates with selected cancers or osteoporosis. Pharmacoepidemiol Drug Saf. 2012;21:810-817.
13. Chung YS, Lee MD, Lee SK, Kim HM, Fitzpatrick LA. HMG-CoA reductase inhibitors increase BMD in type 2 diabetes mellitus patients. J Clin Endocrinol Metab. 2000;85:1137-1142.
14. Grey A, Bolland M, Gamble G, et al. The peroxisome proliferatoractivated receptor-α agonist rosiglitazone decreases bone formation and bone mineral density in healthy postmenopausal women: a randomized, controlled trial. J Clin Endocrinol Metab. 2007;92:1305-1310.
15. Sima C, Glogauer M. Diabetes mellitus and periodontal diseases. Curr Diab Rep. 2013;13:445-452.
16. Conte Neto N, Bastos AS, Chierici-Marcantonio RA, Marcantonio E Jr. Is rheumatoid arthritis a risk factor for oral bisphosphonateinduced osteonecrosis of the jaws? Med Hypotheses. 2011;77:905-911.